Reframing the Debate on Abortion Drugs in an Era of Misinformation
DOI:
https://doi.org/10.63501/a62q4316Keywords:
Abortion, Medical Abortion, Mifepristone, Misoprostol, Mifeprex, RU-486, CytotecAbstract
N/A
References
American College of Obstetricians and Gynecologists. (2020). Medication abortion up to 70 days of gestation (Practice Bulletin No. 225). https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/10/medication-abortion-up-to-70-days-of-gestation
Zhang J, Zhou K, Shan D, Luo X. Medical methods for first-trimester abortion. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD002855. https://doi.org/10.1002/14651858.CD002855.pub5
Endler, M., Lavelanet, A., Cleeve, A., Ganatra, B., Gomperts, R., & Gemzell-Danielsson, K. (2019). Telemedicine for medical abortion: A systematic review. BJOG: An International Journal of Obstetrics & Gynecology, 126(9), 1094–1102. https://doi.org/10.1111/1471-0528.15684
Jung, C., Oviedo, J., & Nippita, S. (2023). Abortion care in the United States: Current evidence and future directions. NEJM Evidence, 2(4), EVIDra2200300. https://doi.org/10.1056/EVIDra2200300
World Health Organization. (2022). Abortion care guideline. https://www.who.int/publications/i/item/9789240039483